NAS:TBIO (USA)

Translate Bio Inc

$ 8.34 0 (0%)
Volume: 106,505 Avg Vol (1m): 253,165
Market Cap $: 425.43 Mil Enterprise Value $: 291.38 Mil
P/E (TTM): 0.00 P/B: 3.25
Earnings Power Value 0
Net Current Asset Value -0.73
Tangible Book -0.25
Projected FCF 0
Median P/S Value 16.21
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 3.8/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 11.46
Cash-To-Debt range over the past 10 years
Min: 9.49, Med: 10000, Max: 10000
Current: 11.46
9.49
10000
Equity-to-Asset 0.38
Equity-to-Asset range over the past 10 years
Min: 0.34, Med: 0.4, Max: 0.44
Current: 0.38
0.34
0.44
Debt-to-Equity 0.11
Debt-to-Equity range over the past 10 years
Min: 0.11, Med: 0.12, Max: 0.14
Current: 0.11
0.11
0.14
Debt-to-EBITDA -0.12
Debt-to-EBITDA range over the past 10 years
Min: -0.12, Med: 0, Max: 0
Current: -0.12
-0.12
0
Altman Z-Score -0.75
DISTRESS
GREY
SAFE

Profitability & Growth : 1/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -2831.24
Operating Margin range over the past 10 years
Min: -7340.14, Med: -7340.14, Max: -2831.24
Current: -2831.24
-7340.14
-2831.24
Net Margin % -2696.98
Net Margin range over the past 10 years
Min: -6858.8, Med: -6858.8, Max: -2696.98
Current: -2696.98
-6858.8
-2696.98
ROE % -167.70
ROE range over the past 10 years
Min: -612.93, Med: -612.93, Max: -167.7
Current: -167.7
-612.93
-167.7
ROA % -40.97
ROA range over the past 10 years
Min: -40.97, Med: -32.88, Max: -12.99
Current: -40.97
-40.97
-12.99
ROC (Joel Greenblatt) % -785.92
ROC (Joel Greenblatt) range over the past 10 years
Min: -1362, Med: -1224.58, Max: -551.59
Current: -785.92
-1362
-551.59

Ratios

Current vs industry vs history
PB Ratio 3.25
PB Ratio range over the past 10 years
Min: 1.85, Med: 3.33, Max: 6.15
Current: 3.25
1.85
6.15
PS Ratio 94.77
PS Ratio range over the past 10 years
Min: 92.39, Med: 184.19, Max: 2314
Current: 94.77
92.39
2314
EV-to-EBIT -2.53
EV-to-EBIT range over the past 10 years
Min: -4.2, Med: -2.4, Max: -0.7
Current: -2.53
-4.2
-0.7
EV-to-EBITDA -2.61
EV-to-EBITDA range over the past 10 years
Min: -4.3, Med: -2.4, Max: -0.7
Current: -2.61
-4.3
-0.7
EV-to-Revenue 71.63
EV-to-Revenue range over the past 10 years
Min: 64.5, Med: 118.4, Max: 1463.9
Current: 71.63
64.5
1463.9
Current Ratio 7.67
Current Ratio range over the past 10 years
Min: 1.69, Med: 6.85, Max: 16.7
Current: 7.67
1.69
16.7
Quick Ratio 7.67
Quick Ratio range over the past 10 years
Min: 1.69, Med: 6.85, Max: 16.7
Current: 7.67
1.69
16.7

Dividend & Buy Back

Current vs industry vs history

Valuation & Return

Current vs industry vs history
Price-to-Median-PS-Value 0.52
Price-to-Median-PS-Value range over the past 10 years
Min: 0.52, Med: 1.09, Max: 10.87
Current: 0.52
0.52
10.87
Earnings Yield (Joel Greenblatt) % -39.53
Earnings Yield (Greenblatt) range over the past 10 years
Min: -146.7, Med: -42.5, Max: -23.9
Current: -39.53
-146.7
-23.9

» TBIO's 30-Y Financials

Financials (Next Earnings Date: 2019-11-08)

» Interactive Chart

Peter Lynch Chart

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:TBIO

Business Description

Industry Biotechnology » Biotechnology    NAICS : 325412    SIC : 2833
Compare
Traded in other countries
Address 29 Hartwell Avenue, Lexington, MA, USA, 02421

More Statistics

Revenue (TTM) (Mil) $ 4.07
EPS (TTM) $ -2.41
Beta 0
Volatility % 112.01
52-Week Range $ 4.81 - 14.34
Shares Outstanding (Mil) 51.01

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 0
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA N
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N